Appropriate Injection Intervals of Dupilumab in Patients With Adult Atopic Dermatitis: A Step Toward Developing Guidelines for Daily Practice
Patients with extended dosing intervals demonstrated sustained effectiveness. Dose tapering might be a valuable option for non-obese patients with positive clinical response characterized by an EASI score under 4 and IgE levels under 1,000 at week 40.
Authors
- Ji‐Hye Park (ORCID: https://orcid.org/0000-0002-6699-5202)
- Joonho Shim (ORCID: https://orcid.org/0000-0002-3974-1290)
- Se Jin Oh (ORCID: https://orcid.org/0000-0001-7525-4740)
- Hyungrye Noh (ORCID: https://orcid.org/0000-0001-7871-8782)
- Heeyeon Kim (ORCID: https://orcid.org/0000-0003-3040-6098)
- Dong‐Youn Lee (ORCID: https://orcid.org/0000-0003-0765-9812)
- Byeonghyun Joo (ORCID: https://orcid.org/0009-0007-5045-5619)
- Jong Hee Lee (ORCID: https://orcid.org/0000-0001-8536-1179)
Institutions
- Samsung (South Korea) (KR)
- Samsung Medical Center (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Annals of Dermatology
- Published
- 2024-10-23
- DOI
- https://doi.org/10.5021/ad.24.084
- Citations
- 7
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 3.74